Found: 8
Select item for more details and to access through your institution.
A Response to Splawn.
- Published in:
- Utilitas, 2001, v. 13, n. 3, p. 334, doi. 10.1017/S0953820800003216
- By:
- Publication type:
- Article
Large multicenter randomized trials in autism: key insights gained from the balovaptan clinical development program.
- Published in:
- Molecular Autism, 2022, v. 13, n. 1, p. 1, doi. 10.1186/s13229-022-00505-6
- By:
- Publication type:
- Article
THE PREDICTIVE UTILITY OF COGNITIVE MEASURES AT SCREENING FOR DETERMINATION OF CSF ABETA (1-42) STATUS IN SUBJECTS WITH PRODROMAL ALZHEIMER'S DISEASE: DATA FROM THE SCARLET ROAD TRIAL.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2016, v. 12, p. P821, doi. 10.1016/j.jalz.2016.06.1668
- By:
- Publication type:
- Article
Efficacy and safety of gantenerumab in prodromal Alzheimer’s disease: Results from scarlet road—a global, multicenter trial.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2015, v. 11, n. 7, p. P331, doi. 10.1016/j.jalz.2015.08.153
- By:
- Publication type:
- Article
UTILITARIANISM, INTEGRITY, AND PARTIALITY.
- Published in:
- Journal of Philosophy, 2000, v. 97, n. 8, p. 421, doi. 10.2307/2678423
- By:
- Publication type:
- Article
In What Sense Is the Right to Subsistence a Basic Right?
- Published in:
- Journal of Social Philosophy, 2009, v. 40, n. 4, p. 488, doi. 10.1111/j.1467-9833.2009.01467.x
- By:
- Publication type:
- Article
Correction to: A phase III randomized trial of gantenerumab in prodromal Alzheimer's disease.
- Published in:
- 2018
- By:
- Publication type:
- Correction Notice
A phase III randomized trial of gantenerumab in prodromal Alzheimer's disease.
- Published in:
- Alzheimer's Research & Therapy, 2017, v. 9, p. 1, doi. 10.1186/s13195-017-0318-y
- By:
- Publication type:
- Article